{
    "hands_on_practices": [
        {
            "introduction": "A primary goal in controlling a vaccine-preventable disease is to achieve herd immunity, where transmission becomes unsustainable. This practice demonstrates how to translate core epidemiological parameters—the basic reproduction number ($R_0$) and vaccine efficacy ($VE$)—into an actionable public health target: the minimum vaccination coverage required to stop an outbreak . By working through this calculation, you will gain insight into the fundamental logic that guides national and global vaccination strategies.",
            "id": "4564302",
            "problem": "A region is preparing for a novel respiratory pathogen emergency using principles from the Susceptible-Infectious-Recovered (SIR) model, under homogeneous mixing with negligible prior immunity. The basic reproduction number $R_0$ is defined as the average number of secondary infections caused by a single infectious individual in a fully susceptible population. The effective reproduction number $R_e$ is defined as the average number of secondary infections under current conditions and is proportional to the proportion of the population that remains susceptible. A vaccine is available that reduces susceptibility to infection with vaccine efficacy (VE) against infection, denoted $VE$, and a fraction $c$ of the population can be vaccinated rapidly.\n\nUsing the definitions above, derive from first principles the minimal vaccination coverage $c_{\\min}$ required for outbreak control (i.e., $R_e < 1$) in terms of $R_0$ and $VE$. Then compute the numerical value of $c_{\\min}$ for $R_0=3$ and $VE=0.8$. Round your answer to four significant figures and express it as a decimal fraction with no units.\n\nSeparately, the region’s current capacity allows vaccinating at most $0.70$ of the population in the initial $8$ weeks. Based on your computed $c_{\\min}$, briefly interpret whether achieving control solely via vaccination in this initial period is feasible and why, assuming no additional measures are implemented.",
            "solution": "The starting point is the definition of the effective reproduction number $R_e$ in a homogeneously mixing population. When a fraction $S$ of the population is susceptible, the effective reproduction number satisfies\n$$\nR_e = R_0 \\times S.\n$$\nTo achieve outbreak control, one requires\n$$\nR_e < 1.\n$$\nWe now express $S$ in terms of the vaccination coverage $c$ and the vaccine efficacy against infection $VE$. Assume a fraction $c$ of individuals are vaccinated and a fraction $1-c$ are unvaccinated. Unvaccinated individuals have susceptibility $1$. Vaccinated individuals have their susceptibility reduced by the vaccine efficacy $VE$, so their susceptibility is $1-VE$. The average susceptibility in the population is therefore the weighted mean\n$$\nS = (1-c)\\times 1 + c \\times (1-VE) = 1 - c\\,VE.\n$$\nSubstituting this expression into $R_e$ gives\n$$\nR_e = R_0 \\times (1 - c\\,VE).\n$$\nThe outbreak-control condition becomes\n$$\nR_0 \\times (1 - c\\,VE) < 1.\n$$\nSolving this inequality for $c$ yields\n\n$$\n1 - c\\,VE < \\frac{1}{R_0}\n\\quad \\Longrightarrow \\quad\nc\\,VE > 1 - \\frac{1}{R_0}\n\\quad \\Longrightarrow \\quad\nc > \\frac{1 - \\frac{1}{R_0}}{VE}.\n$$\n\nHence, the minimal vaccination coverage required for control is\n$$\nc_{\\min} = \\frac{1 - \\frac{1}{R_0}}{VE}.\n$$\n\nWe now compute $c_{\\min}$ for $R_0 = 3$ and $VE = 0.8$:\n\n$$\nc_{\\min} = \\frac{1 - \\frac{1}{3}}{0.8} = \\frac{\\frac{2}{3}}{0.8} = \\frac{2}{3} \\times \\frac{1}{0.8} = \\frac{2}{3} \\times 1.25 = \\frac{5}{6}.\n$$\n\nThe exact value is $\\frac{5}{6}$, which in decimal form is\n\n$$\nc_{\\min} = 0.833333\\ldots.\n$$\n\nRounded to four significant figures, this is\n\n$$\nc_{\\min} = 0.8333.\n$$\n\n\nInterpretation of feasibility with the stated capacity constraint: the region can vaccinate at most $0.70$ of the population initially, but $c_{\\min} \\approx 0.8333$ is greater than $0.70$. Therefore, achieving $R_e < 1$ solely through vaccination during the initial $8$ weeks is not feasible under the current capacity constraint. Without additional measures (such as increasing vaccination capacity, accelerating rollout, or implementing non-pharmaceutical interventions that reduce contact rates and effectively lower $R_0$), the outbreak would not be controlled in this period by vaccination alone.",
            "answer": "$$\\boxed{0.8333}$$"
        },
        {
            "introduction": "While vaccination is a powerful tool, non-pharmaceutical interventions (NPIs) like face masks are crucial for a comprehensive emergency response. This exercise moves beyond simple declarations of effectiveness to quantify their impact in a realistic household setting . You will model how a mask's protective efficacy combines with population compliance to reduce the secondary attack rate, highlighting the critical interplay between an intervention's physical properties and human behavior.",
            "id": "4564344",
            "problem": "In a household during a respiratory virus outbreak, the Secondary Attack Rate (SAR) is the probability that a susceptible household member becomes infected following exposure to a single index case in the absence of any intervention. Suppose the baseline SAR is $A_{0} = 0.25$. Consider a non-pharmaceutical intervention involving face masks as part of public health emergency preparedness and response. Let mask efficacy be defined as $E$, where each correctly worn mask reduces the per-contact transmission probability multiplicatively by a factor of $(1 - E)$ for the wearer (source control for the index case and protection for the susceptible contact). Let compliance be defined as $c$, the probability that any given household member (index or contact) wears a mask during exposure, with independent compliance between the two individuals.\n\nAssume that:\n- Each transmission-relevant exposure is pairwise between one index case and one susceptible contact.\n- Mask wearing by the index case and the susceptible contact are independent events, each occurring with probability $c$.\n- The residual transmission probability for a pair is multiplicatively reduced by $(1 - E)$ for each masked individual in that pair.\n- There are no other concurrent interventions and no changes to exposure frequency.\n\nGiven mask efficacy $E = 0.5$ and compliance $c = 0.8$, compute the adjusted SAR under these assumptions using the multiplicative reduction model described above. Express your final answer as a decimal fraction. No rounding is required beyond what is implied by exact arithmetic.",
            "solution": "The problem statement is first subjected to validation.\n\n**Step 1: Extract Givens**\n- Baseline Secondary Attack Rate (SAR): $A_{0} = 0.25$\n- Mask efficacy: $E$\n- Multiplicative reduction factor per mask: $(1 - E)$\n- Compliance (probability of wearing a mask): $c$\n- Mask wearing by the index case and susceptible contact are independent events.\n- Given values for calculation: $E = 0.5$ and $c = 0.8$.\n- Objective: Compute the adjusted SAR, denoted here as $A_{adj}$.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is assessed against the required criteria:\n- **Scientifically Grounded:** The problem uses a simplified but standard epidemiological model to assess the impact of a non-pharmaceutical intervention. The concepts of Secondary Attack Rate (SAR), mask efficacy ($E$), and compliance ($c$) are fundamental in public health and infectious disease modeling. The multiplicative reduction model is a common and plausible assumption for such analyses. The problem is directly relevant to the topic of *public health emergency preparedness and response* within the field of *preventive medicine*.\n- **Well-Posed:** The problem is mathematically well-defined. It provides all necessary parameters ($A_{0}$, $E$, $c$) and specifies the relationships between them (multiplicative reduction, independent compliance). This setup allows for the calculation of a unique and meaningful solution.\n- **Objective:** The problem is stated in precise, quantitative, and unbiased language. All terms are clearly defined within the context of the model.\n\nThe problem exhibits no flaws such as scientific unsoundness, missing information, contradiction, or subjectivity. It is a formalizable and standard exercise in quantitative public health.\n\n**Step 3: Verdict and Action**\nThe problem is deemed **valid**. A solution will be derived.\n\nThe adjusted Secondary Attack Rate, $A_{adj}$, is the expected probability of transmission given the intervention. We can calculate this using the law of total probability, averaging over all possible masking scenarios. However, a more direct approach is to determine the average multiplicative reduction in transmission probability and apply it to the baseline SAR, $A_{0}$.\n\nLet's consider one side of the transmission pair, for instance, the index case. This individual wears a mask with probability $c$ or does not wear one with probability $(1-c)$.\n- If a mask is worn (probability $c$), the transmission probability is reduced by a factor of $(1-E)$.\n- If a mask is not worn (probability $1-c$), the reduction factor is $1$ (i.e., no reduction).\n\nThe expected reduction factor from a single individual's (either source or contact) potential mask-wearing is the weighted average of these two outcomes:\n$$R_{individual} = c \\cdot (1-E) + (1-c) \\cdot 1$$\nSimplifying this expression:\n$$R_{individual} = c - cE + 1 - c = 1 - cE$$\n\nThe problem states that mask-wearing by the index case and the susceptible contact are independent events, and the reduction effects are multiplicative. Therefore, the total average reduction factor, $R_{total}$, for the pair is the product of the individual average reduction factors for the source and the contact:\n$$R_{total} = R_{source} \\cdot R_{contact} = (1 - cE) \\cdot (1 - cE) = (1 - cE)^2$$\n\nThe adjusted SAR, $A_{adj}$, is the baseline SAR, $A_{0}$, multiplied by this total average reduction factor:\n$$A_{adj} = A_{0} \\cdot R_{total} = A_{0} (1 - cE)^2$$\n\nNow, we substitute the given numerical values into this derived formula:\n- Baseline SAR, $A_{0} = 0.25$\n- Mask efficacy, $E = 0.5$\n- Compliance, $c = 0.8$\n\nThe term $cE$ is:\n$$cE = 0.8 \\times 0.5 = 0.4$$\n\nSubstituting this into the expression for $A_{adj}$:\n$$A_{adj} = 0.25 \\times (1 - 0.4)^2$$\n$$A_{adj} = 0.25 \\times (0.6)^2$$\n$$A_{adj} = 0.25 \\times 0.36$$\n\nTo perform the final multiplication, we can express $0.25$ as $\\frac{1}{4}$:\n$$A_{adj} = \\frac{1}{4} \\times 0.36 = 0.09$$\n\nThus, the adjusted Secondary Attack Rate under the specified conditions of mask efficacy and compliance is $0.09$.",
            "answer": "$$\\boxed{0.09}$$"
        },
        {
            "introduction": "Effective surveillance and case management rely on accurate diagnostic testing, but a test's performance in the real world is more complex than its lab-rated accuracy. This practice applies Bayes' theorem to calculate a test's Positive and Negative Predictive Values (PPV and NPV), revealing how profoundly the disease prevalence in a population affects the meaning of a positive or negative result . Mastering this concept is essential for making sound clinical judgments and avoiding misinterpretation of surveillance data during a public health emergency.",
            "id": "4564351",
            "problem": "During a sudden surge of influenza-like illness in a metropolitan area, the health department deploys a rapid diagnostic test to triage patients for isolation and antiviral treatment in a community assessment center. The test’s sensitivity, defined as the probability of a positive test result given true disease, is $0.9$, and its specificity, defined as the probability of a negative test result given no disease, is $0.98$. The estimated point prevalence among persons presenting to the center is $0.05$. Using Bayes’ theorem and only the core definitions of sensitivity, specificity, prevalence, and the law of total probability, derive expressions for the Positive Predictive Value (PPV) and Negative Predictive Value (NPV), and then compute their numerical values. Express each value as an exact fraction (do not round or use a percentage sign). Report your final answer as the ordered pair $(\\mathrm{PPV}, \\mathrm{NPV})$.",
            "solution": "The problem is subjected to validation against the provided criteria.\n\nStep 1: Extract Givens\n- Sensitivity (probability of a positive test given disease): $\\text{Sens} = 0.9$\n- Specificity (probability of a negative test given no disease): $\\text{Spec} = 0.98$\n- Prevalence (a priori probability of disease): $\\text{Prev} = 0.05$\n- The task is to derive expressions for Positive Predictive Value ($\\mathrm{PPV}$) and Negative Predictive Value ($\\mathrm{NPV}$) using Bayes’ theorem, definitions, and the law of total probability, and then compute their numerical values as exact fractions.\n\nStep 2: Validate Using Extracted Givens\n- **Scientific Grounding**: The problem is grounded in the fundamental principles of probability theory (Bayes' theorem, law of total probability) and its standard application in medical diagnostics and epidemiology. The concepts of sensitivity, specificity, prevalence, PPV, and NPV are core to this field.\n- **Well-Posedness**: The problem provides all necessary data and a clear objective. The values are consistent and permit the calculation of a unique, meaningful solution.\n- **Objectivity**: The problem is stated in precise, objective language using standard, unambiguous definitions.\n- **Verdict**: The problem is scientifically sound, self-contained, and well-posed. No flaws are identified. Therefore, it is deemed **valid**.\n\nProceeding to the solution.\n\nLet $D$ be the event that a person has the disease, and $D^c$ be the event that the person does not have the disease. Let $T^+$ be the event of a positive test result and $T^-$ be the event of a negative test result.\n\nThe given information can be formulated in terms of conditional probabilities:\n- Prevalence is the prior probability of having the disease: $P(D) = \\text{Prev} = 0.05$.\n- The probability of not having the disease is the complement: $P(D^c) = 1 - P(D) = 1 - 0.05 = 0.95$.\n- Sensitivity is the probability of a positive test given the disease: $P(T^+ | D) = \\text{Sens} = 0.9$.\n- Specificity is the probability of a negative test given no disease: $P(T^- | D^c) = \\text{Spec} = 0.98$.\n\nFrom these definitions, we can also determine the probabilities of the complementary events:\n- The probability of a false negative (negative test given disease) is $P(T^- | D) = 1 - P(T^+ | D) = 1 - \\text{Sens} = 1 - 0.9 = 0.1$.\n- The probability of a false positive (positive test given no disease) is $P(T^+ | D^c) = 1 - P(T^- | D^c) = 1 - \\text{Spec} = 1 - 0.98 = 0.02$.\n\nThe quantities to be calculated are:\n- Positive Predictive Value ($\\mathrm{PPV}$), which is the probability of having the disease given a positive test result: $\\mathrm{PPV} = P(D | T^+)$.\n- Negative Predictive Value ($\\mathrm{NPV}$), which is the probability of not having the disease given a negative test result: $\\mathrm{NPV} = P(D^c | T^-)$.\n\nWe will use Bayes' theorem to derive the expressions for $\\mathrm{PPV}$ and $\\mathrm{NPV}$.\n\n**Derivation and Calculation of Positive Predictive Value ($\\mathrm{PPV}$)**\nBayes' theorem for $\\mathrm{PPV}$ is:\n$$ \\mathrm{PPV} = P(D | T^+) = \\frac{P(T^+ | D) P(D)}{P(T^+)} $$\nThe denominator, $P(T^+)$, is the total probability of a positive test. It can be expanded using the law of total probability:\n$$ P(T^+) = P(T^+ | D) P(D) + P(T^+ | D^c) P(D^c) $$\nSubstituting the definitions of sensitivity, specificity, and prevalence into the expression for $P(T^+)$:\n$$ P(T^+) = (\\text{Sens})(\\text{Prev}) + (1 - \\text{Spec})(1 - \\text{Prev}) $$\nTherefore, the general expression for $\\mathrm{PPV}$ is:\n$$ \\mathrm{PPV} = \\frac{(\\text{Sens})(\\text{Prev})}{(\\text{Sens})(\\text{Prev}) + (1 - \\text{Spec})(1 - \\text{Prev})} $$\nNow, we substitute the numerical values:\n$$ \\mathrm{PPV} = \\frac{(0.9)(0.05)}{(0.9)(0.05) + (1 - 0.98)(1 - 0.05)} $$\n$$ \\mathrm{PPV} = \\frac{0.045}{0.045 + (0.02)(0.95)} $$\n$$ \\mathrm{PPV} = \\frac{0.045}{0.045 + 0.019} $$\n$$ \\mathrm{PPV} = \\frac{0.045}{0.064} $$\nTo express this as an exact fraction, we can multiply the numerator and denominator by $1000$:\n$$ \\mathrm{PPV} = \\frac{45}{64} $$\nThe greatest common divisor of $45$ ($3^2 \\times 5$) and $64$ ($2^6$) is $1$, so the fraction is in its simplest form.\n\n**Derivation and Calculation of Negative Predictive Value ($\\mathrm{NPV}$)**\nBayes' theorem for $\\mathrm{NPV}$ is:\n$$ \\mathrm{NPV} = P(D^c | T^-) = \\frac{P(T^- | D^c) P(D^c)}{P(T^-)} $$\nThe denominator, $P(T^-)$, is the total probability of a negative test. Using the law of total probability:\n$$ P(T^-) = P(T^- | D^c) P(D^c) + P(T^- | D) P(D) $$\nSubstituting the definitions of sensitivity, specificity, and prevalence:\n$$ P(T^-) = (\\text{Spec})(1 - \\text{Prev}) + (1 - \\text{Sens})(\\text{Prev}) $$\nTherefore, the general expression for $\\mathrm{NPV}$ is:\n$$ \\mathrm{NPV} = \\frac{(\\text{Spec})(1 - \\text{Prev})}{(\\text{Spec})(1 - \\text{Prev}) + (1 - \\text{Sens})(\\text{Prev})} $$\nNow, we substitute the numerical values:\n$$ \\mathrm{NPV} = \\frac{(0.98)(1 - 0.05)}{(0.98)(1 - 0.05) + (1 - 0.9)(0.05)} $$\n$$ \\mathrm{NPV} = \\frac{(0.98)(0.95)}{(0.98)(0.95) + (0.1)(0.05)} $$\n$$ \\mathrm{NPV} = \\frac{0.931}{0.931 + 0.005} $$\n$$ \\mathrm{NPV} = \\frac{0.931}{0.936} $$\nTo express this as an exact fraction, we multiply the numerator and denominator by $1000$:\n$$ \\mathrm{NPV} = \\frac{931}{936} $$\nThe prime factorization of the numerator is $931 = 7^2 \\times 19$. The prime factorization of the denominator is $936 = 2^3 \\times 3^2 \\times 13$. They share no common factors, so the fraction is in its simplest form.\n\nThe final answer is the ordered pair $(\\mathrm{PPV}, \\mathrm{NPV})$.",
            "answer": "$$\n\\boxed{(\\frac{45}{64}, \\frac{931}{936})}\n$$"
        }
    ]
}